期刊名称：INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ISSN： 1178-2005 出版频率： Continuous publication 出版社： DOVE MEDICAL PRESS LTD, PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752   出版社网址： http://www.dovepress.com/ 期刊网址： http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journal 影响因子： 3.355 主题范畴： RESPIRATORY SYSTEM 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal International Journal of Chronic Obstructive Pulmonary Disease ISSN: 1178-2005 ISSN 1176-9106 (Print) - went to online only in 2009 An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals. Journal Impact Factor: 2.732 This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). Indexed online: PubMed and PubMed Central (Int J Chron Obstruct Pulmon Dis) MedLine Science Citation Index Expanded (also known as SciSearch®) Journal Citation Reports American Chemical Society's 'Chemical Abstracts Service' (CAS) Embase, Scopus and the Elsevier Bibliographic databases Directory of Open Access Journals (DOAJ) OAIster: The Open Access Initiative Bereavement Notice: We are saddened to hear that Editorial Board member, Professor Maurizio Luisetti, has passed away after a brief illness. Our thoughts are with his family, friends and colleagues at this difficult time. USA/Canada UK Rest-of-World US$2200.00 £1395.00 €1595.00 Aims and Scope The International Journal of Chronic Obstructive Pulmonary Disease is an international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals.   Instructions to Authors Preparation of Manuscript Include: Forename(s) and surnames of authors (see Authorship section below) Author affiliations: department, institution, city, state, country Abstract 300 words 3–6 keywords Running header (shortened title) Corresponding author: name, physical address, phone, fax, email Reference list Double-spacing 3-cm margins Page numbers Clear concise language American spelling Ensure tables and figures are cited  The preferred electronic format for text is Microsoft Word Manuscripts will be accepted in LaTeX as long as the native LaTeX and a PDF is also supplied Use International Systems of Units (SI) symbols and recognized abbreviations for units of measurement Do not punctuate abbreviations eg, et al, ie Spell out acronyms in the first instance in the abstract and paper Word counts are not specified. In general, shorter items range from 1000 to 3000 words and reviews from 3000 to 7,500 Generic drug names are used in text, tables, and figures Suppliers of drugs, equipment, and other brand-name material are credited in parentheses (company, name, city, state, country) If molecular sequences are used, provide a statement that the data have been deposited in a publicly accessible database, eg, GenBank, and indicate the database accession number. While the editors fully understand the extra challenges posed to authors whose native language is not English, we must ask that all manuscripts be reviewed and edited by a native speaker of English with expertise in that area prior to submission. Authorship Authorship credit should be based on: 1) Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) Drafting the article or revising it critically for important intellectual content;  3) Final approval of the version to be published; and 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions 1, 2, 3, and 4. When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript (3). These individuals should fully meet the criteria for authorship/contributorship defined above, and editors will ask these individuals to complete journal-specific author and conflict-of-interest disclosure forms. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. The NLM indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript; it also lists the names of collaborators if they are listed in Acknowledgments. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. All persons designated as authors should qualify for authorship, and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Increasingly, authorship of multicenter trials is attributed to a group. All members of the group who are named as authors should fully meet the above criteria for authorship/contributorship. The group should jointly make decisions about contributors/authors before submitting the manuscript for publication. The corresponding author/guarantor should be prepared to explain the presence and order of these individuals. It is not the role of editors to make authorship/contributorship decisions or to arbitrate conflicts related to authorship. Contributors Listed in Acknowledgments All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chairperson who provided only general support. Authors should declare whether they had assistance with study design, data collection, data analysis, or manuscript preparation. If such assistance was available, the authors should disclose the identity of the individuals who provided this assistance and the entity that supported it in the published article. Financial and material support should also be acknowledged. Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under such headings as “clinical investigators” or “participating investigators,” and their function or contribution should be described—for example, “served as scientific advisors,” “critically reviewed the study proposal,” “collected data,” or “provided and cared for study patients.” Because readers may infer their endorsement of the data and conclusions, these persons must give written permission to be acknowledged. Please note: the Authorship and “Contributors Listed in Acknowledgments” sections are reprinted from the ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Dove Medical Press  prepared this reprint. The ICMJE has not endorsed nor approved the contents of this reprint. The official version of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals is located at http://www.icmje.org/. Users should cite this official version when citing the document. Related Authors Where authors of a paper are related this should be disclosed at the time of submission. Please provide details of the family relationship between such authors. Figures and Tables Submit as separate files and also as one combined file Submit figures as JPG files Number consecutively Provide a descriptive heading/legend Place abbreviations immediately below the table Use superscript a, b, c… as identifiers Supply Line Art 900 dpi, Combination (Line Art + Halftone) 900 dpi, Halftone 300 dpi Graphics downloaded from Web pages are NOT acceptable Submit multi-panel figures, ie with parts labeled a,b,c,d, as one file Supplementary Data Any supplementary data should be kept to 6 typeset pages or 2,400 words. If you have any more than this you should provide a link to the supplementary data on an external website, your institute’s website for example, and/or Dove Medical Press may be able to upload the raw supplementary data to the http://www.dovepress.com/ website and provide a link in your paper. We welcome video files either as supplementary data or as part of the actual manuscript to show operations, procedures, etc.   Letter to the Editor Manuscripts submitted as a Letter to the Editor: Should relate to a paper previously published in a Dove Medical Press journal, or address an issue of wider concern within the scope of the journal; Have a word count of no more than 3,600 words; May contain figures and tables (see specifications for these above); Have references formatted in the Dove Medical Press style. Submission of Manuscript All manuscripts should be submitted via our website.   By doing so you agree to the terms and conditions of submission Keep a backup and hard copies of the material submitted Pre-submissions Authors are welcome to send an abstract or draft manuscript to obtain a view from the Editor about the suitability of their paper. Please email here and include which journal you are interested in submitting your manuscript to. Our Editors will do a quick review (not peer review) of your paper and advise if they believe it is appropriate for submission to their journal. This will be based on subject matter vs the aims and scope of the journal. It will not be a full review of your manuscript. Reference Style See Reference Style Guidelines   Proofs You will receive the typeset page proofs for approval Check amendments made by the editor have not rendered the material inaccurate Check you have answered all the editor’s queries Ensure your corrections are minimal and absolutely necessary Mark the adjustments clearly in the text and margins, and keep a copy of what you send to the editor Notify the editorial office of all corrections within 72 hours of your receipt of the material Ensure all authors sign and return the Author Approval and final page of Publication Agreement   All Dove journals are members of and subscribe to the principles of the Committee on Publication Ethics (COPE). We also support the international standards for editors and authors that were developed at the 2nd World Conference on Research Integrity in Singapore in 2010. Editorial Board Dr Russell Editor in Chief Dr Russell Founding Editor: Dr Richard E Russell Dr Richard Russell was trained at Guy’s Hospital with further postgraduate training at St Bartholomews and St George’s Hospitals in London. He was trained in respiratory medicine in the Southeast Thames Region and at the Royal Brompton Hospital. Dr Russell has been a Consultant at Wexham Park and Windsor Hospitals for two years and has special interests in COPD, asthma, and delivery of care. During his time at the Royal Brompton, he completed a PhD as a British Lung Foundation Research Fellow under the supervision of Professor Peter Barnes. The research focussed on the basic mechanisms of COPD and disease progression in a population of smokers in primary care, and this is a continuing area of study. Dr Russell has interests in obstructive lung disease, particularly pathophysiology of COPD and how patients should be cared for across the primary/secondary care interface. He is a member of the British Thoracic Society Executive, Scientific Committee and the Communications Committee, is active in the British Lung Foundation, and was recently involved in drawing up the new asthma guidelines. As editor of the International Journal of COPD, Dr Russell is keen to increase the awareness of COPD and provide a platform for advances in the understanding of COPD pathology, which are so desperately needed. Dr Bafadhel Associate Editor in Chief Dr Bafadhel Commissioning Editor: Mona Bafadhel Dr Bafadhel obtained her medical degree at the University of Birmingham and trained as a junior doctor at the Heartlands Hospital in Birmingham. She became interested in Respiratory medicine and continued further training at the Royal Brompton Hospital and continuing her specialist registrar training in Oxford.   Following her PhD at the University of Leicester, which investigated biomarkers in COPD exacerbations, Dr Bafadhel was appointed as an NIHR Clinical Lecturer in Respiratory Medicine to continue her research into phenotyping and the management of COPD. Prof. Dr. Bai Associate Editor in Chief Prof. Dr. Bai Associate Editor for China, East Asia and South East Asia: Chunxue Bai Chunxue Bai is Professor and Chair of the Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University. He is also the Founder and Director of the Shanghai Respiratory Research Institute.  Dr. Bai serves as Chair for the Chinese Alliance against Lung Cancer, Vice President of the Chinese Respiratory Association, and Chair of the research committee for the Asian Pacific Society of Respirology (APSR). Dr Bai is the Chief Editor for Translational Respiratory Medicine. He also serves as an international editorial board member for AJRCCM, AJRCMB, Chest and is an associate editor for the Journal of Clinical Bioinformatics. He is the Founder and Chair of the International Symposium on Respiratory Diseases, which has become one of the largest and leading respiratory conferences in Asia and China. Dr Bai’s main research interests include COPD, asthma, acute lung injury and lung cancer. His major contributions in COPD include early diagnosis using low-dose CT scan, monitoring and management using cell phone-based remote mobile system and biomarker research. He is the author of over 420 publications in prestigious nationally and internationally renowned peer-reviewed journals and has been invited to write more than 30 chapters in reference books and editorials in journals. Dr Bai has been invited to more than 40 international conferences (ATS, ERS, APSR) and academic institutions throughout the world to present the results of his research to esteemed participants. Dr Crockett Associate Editor in Chief Dr Crockett Associate Editor: Alan J. Crockett PSM  Associate Professor Alan J. Crockett recently retired from the position of Chief Medical Scientist, Respiratory Unit at Flinders Medical Centre after a career in respiratory medicine spanning 38 years. Alan Crockett currently holds a fractional-time position of Associate Professor, Director Primary Care Respiratory Unit within the Department of General Practice, University of Adelaide. Alan Crockett has been involved in teaching medical and health science students and researching into critical appraisal and EBM since 1987 and has held the position of Deputy Chair of the Australian Centre of Evidence Based Practice since its inception in 2000. He also Chairs the Steering committee for the University of South Australia’s Centre for Allied Health Evidence. He was the first graduate of the Masters of Public Health at the University of Adelaide and holds qualification in respiratory technology in the USA and Canada and a Graduate Certificate of Health Economics (University of Aberdeen). Alan Crockett was elected Fellow of the Australian Institute of Science Technology in 1976. More recently, he was awarded a Fellowship and Life Membership of the Australian and New Zealand Society for Respiratory Science and Emeritus Member status of the Thoracic Society of Australia and New Zealand for his contribution to respiratory medicine. He was awarded a Public Service Medal for “outstanding contribution to community health” in the Order of Australia Awards for Australia Day 2003. Dr Mannino Associate Editor in Chief Dr Mannino Associate Editor: David Mannino David Mannino, MD, is a Professor and Chair in Department of Preventive Medicine and Environmental Health at the University of Kentucky College of Public Health in Lexington, Kentucky.  He also has an appointment in the Department of Epidemiology in the College of Public Health and the Division of Pulmonary and Critical Care Medicine in the Department of Medicine at the University of Kentucky College of Medicine.  He is the Director of the Pulmonary Epidemiology Research Laboratory.  Having obtained his medical degree from Jefferson Medical College in 1981, Dr Mannino went on to complete his internship and residency at Lankenau Hospital, both in Philadelphia, Pennsylvania. A fellowship in pulmonary medicine at West Virginia University School of Medicine/National Institute for Occupational Safety and Health in Morgantown, West Virginia, followed. Dr Mannino served as the chief science officer for the Centers for Disease Control and Prevention’s Air Pollution and Respiratory Health branch following his fellowship until his retirement in 2004. Dr. Mannino has authored over 200 articles for peer-reviewed journals, in addition to book chapters, editorials, and book reviews. His research interests included the epidemiology of asthma and COPD, tobacco use and treatment, and the effects of air pollutant exposure on respiratory function and lung diseases. Dr Rahman Associate Editor in Chief Dr Rahman Associate Editor: Irfan Rahman Dr Irfan Rahman is an Associate Professor of Environmental Medicine, Lung Biology, and Disease Program of the University of Rochester Medical Center, Rochester, NY. He has a dedicated research program to understand the cellular and molecular mechanisms of the pathogenesis of COPD and the potential benefit of therapeutic interventions. Dr Rahman was trained at prestigious institutions involved in state-of-the-art lung research, including Georgetown University, USA and Edinburgh University Medical School, UK. He has spent over 15 years in understanding the lung cellular and molecular responses to inhaled toxicants. Dr Rahman’s main research interests include oxidants, antioxidants, non-invasive biomarkers, and molecular therapeutic targets of transcription factors, chromatin remodeling and proinflammatory mediators in COPD and chronic lung inflammation. He is the author of over one hundred publications in prestigious internationally renowed peer-reviewed journals, and has been invited to write chapters in reference books and editorials in journals. Dr Rahman has been invited to more than 50 national and international conferences (ATS, ERS, Experimental Biology), and to academic institutions throughout the world, to present the results of his research before esteemed audiences. Dr Rahman is an ad-hoc member of the National Institutes of Health/NCI special emphasis study section panel, National Research Council of Canada and is on the program committee roster of the respiratory cellular and molecular biology section of the American Thoracic Society. Alongside the prestigious appointment as an Associate Editor (North America) of the International Journal of COPD, Dr Rahman is also an Associate Editor of the European Respiratory Journal and the Journal of Biochemistry and Molecular Biology. Professor Singh Associate Editor in Chief Professor Singh Associate Editor: Dave Singh Dr Singh is a Senior Lecturer and Consultant Physician, Respiratory Medicine and Clinical Pharmacology. After graduating from Cambridge University, Dave Singh trained in Respiratory Medicine and Clinical Pharmacology in Manchester. As part of his training, he spent time in industry working in Phase 1 respiratory studies, and completing an MD thesis. He is now Senior Lecturer at Manchester University, with clinical commitments at South Manchester University Hospitals Trust. His research is focused on airway inflammation in COPD, with studies of non-invasive biomarkers and basic science studies of airway pharmacology.